
### [NCIT:C7232](http://purl.obolibrary.org/obo/NCIT_C7232)
**Label:** Neoplastic Post-Transplant Lymphoproliferative Disorder

**Subclasses:** [NCIT:C27695](http://purl.obolibrary.org/obo/NCIT_C27695) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7238](http://purl.obolibrary.org/obo/NCIT_C7238) (Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7237](http://purl.obolibrary.org/obo/NCIT_C7237) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7239](http://purl.obolibrary.org/obo/NCIT_C7239) (Hodgkin-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7233](http://purl.obolibrary.org/obo/NCIT_C7233) (Monomorphic Post-Transplant Lymphoproliferative Disorder), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7246](http://purl.obolibrary.org/obo/NCIT_C7246) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7243](http://purl.obolibrary.org/obo/NCIT_C7243) (Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7183](http://purl.obolibrary.org/obo/NCIT_C7183) (Polymorphic Post-Transplant Lymphoproliferative Disorder), 

**Class expressions from DL-Learner:**

- Thing 54.55%
- [NCIT:C40562](http://purl.obolibrary.org/obo/NCIT_C40562) (Transformed Neoplastic Lymphocyte) 52.50%
- [NCIT:C37024](http://purl.obolibrary.org/obo/NCIT_C37024) (Reed-Sternberg-Like Cell) 52.50%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast))) 52.50%
- [NCIT:C36988](http://purl.obolibrary.org/obo/NCIT_C36988) (Neoplastic Lymphocyte) 40.18%
- [NCIT:C36725](http://purl.obolibrary.org/obo/NCIT_C36725) (Abnormal Lymphocyte) 39.82%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 37.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 37.86%


